4.6 Article

Benchmarks for Interpretation of Score Differences on the SF-36 Health Survey for Patients with Diabetes

Journal

VALUE IN HEALTH
Volume 16, Issue 6, Pages 993-1000

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jval.2013.06.022

Keywords

benchmarks; diabetes; interpretation; patient reported outcome; SF-36

Funding

  1. Novo Nordisk

Ask authors/readers for more resources

Objective: To estimate clinical and social benchmarks for inter pretation of score differences on the Short-Form 36 Health Survey, and apply these benchmarks to populations with diabetes mellitus (DM). Methods: Using survival and logistic regression models, we reanalyzed data from three US cohorts: the Medical Outcomes Study (N = 3,445; 541 patients with DM), the Medicare Health Outcomes Survey (N = 78,183; 16,388 patients with DM), and the Quality Metric 2009 Norming Study (N = 4,040; 580 patients with DM). Outcome variables were mortality, hospitalization, current inability to work, and loss of ability to work. Results: Benchmarks were robust across disease groups, but varied according to age and score level. A 1-point lower score on the Physical Function, General Health, and Physical Component Summary scales was associated with a 1.05 to 1.09 relative risk (RR) of mortality for the typical patient with DM, with stronger associations in the younger age groups. For several scales (Physical Function, Role Physical, Bodily Pain, General Health, Vitality, Social Function, and Role Emotional), the associations with mortality also depended on score level, with stronger associations in the lower score ranges (i.e., patients in worse health). A 1-point lower score on the Physical Function, Role Physical, Bodily Pain, General Health, Vitality, Social Function, and Physical Component Summary scales implied a 1.02 to 1.04 RR of hospitalization, a 1.07 to 1.12 RR of being unable to work, and a 1.04 to 1.07 RR of losing the ability to work. Conclusions: A 1-point lower score on selected Short Form 36 Health Survey scales is associated with an excess risk of up to 9% for mortality and 12% for inability to work.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available